{"id":130686,"date":"2017-03-02T01:48:43","date_gmt":"2017-03-02T06:48:43","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/uncategorized\/puma-biotechnology-inc-nasdaqpbyi-files-an-8-k-other-events-market-exclusive.php"},"modified":"2024-08-17T16:07:20","modified_gmt":"2024-08-17T20:07:20","slug":"puma-biotechnology-inc-nasdaqpbyi-files-an-8-k-other-events-market-exclusive","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/puma-biotechnology-inc-nasdaqpbyi-files-an-8-k-other-events-market-exclusive.php","title":{"rendered":"PUMA BIOTECHNOLOGY, INC. (NASDAQ:PBYI) Files An 8-K Other Events &#8211; Market Exclusive"},"content":{"rendered":"<table border=\"0\" cellpadding=\"2\" cellspacing=\"7\" style=\"vertical-align:top;\"><tr><td width=\"80\" align=\"center\" valign=\"top\"><font style=\"font-size:85%;font-family:arial,sans-serif\"><\/font><\/td><td valign=\"top\" class=\"j\"><font style=\"font-size:85%;font-family:arial,sans-serif\"><div style=\"padding-top:0.8em;\"><img alt=\"\" height=\"1\" width=\"1\" style=\"padding-left:10px; padding-right: 10px;\"><\/div><div class=\"lh\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNE_rK0MLnQ09jYO9dbk5zhpCEqMHg&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779404104922&amp;ei=KcC3WMjVL4qX3wGC-YfYAw&amp;url=https:\/\/marketexclusive.com\/puma-biotechnology-inc-nasdaqpbyi-files-an-8-k-other-events-2\/77816\/\"><b>PUMA <b>BIOTECHNOLOGY<\/b>, INC. (NASDAQ:PBYI) Files An 8-K Other Events<\/b><\/a><br><font size=\"-1\"><b><font color=\"#6f6f6f\">Market Exclusive<\/font><\/b><\/font><br><font size=\"-1\">Puma <b>Biotechnology<\/b>, Inc. is a biopharmaceutical company that focuses on the development and commercialization of products for the treatment of cancer. The Company focuses on in-licensing the global development and commercialization rights to over&nbsp;...<\/font><br><font size=\"-1\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNH4xTpKOrwuyBGThzw4loHAefngTg&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779404104922&amp;ei=KcC3WMjVL4qX3wGC-YfYAw&amp;url=http:\/\/www.businesswire.com\/news\/home\/20170301006637\/en\/Puma-Biotechnology-Announces-Publication-Abstracts-Neratinib-AACR\">Puma <b>Biotechnology<\/b> Announces Publication of Abstracts on Neratinib for the AACR Annual Meeting 2017<\/a><font size=\"-1\" color=\"#6f6f6f\"><nobr>Business Wire (press release)<\/nobr><\/font><\/font><br><font size=\"-1\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNGwenM9TzeskE_lcza22HgnR8Ge2Q&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779404104922&amp;ei=KcC3WMjVL4qX3wGC-YfYAw&amp;url=http:\/\/finance.yahoo.com\/news\/puma-biotechnology-reports-fourth-quarter-212000802.html\">Puma Biotechnology Reports Fourth Quarter and Full Year 2016 ...<\/a><font size=\"-1\" color=\"#6f6f6f\"><nobr>Yahoo Finance<\/nobr><\/font><\/font><br><font size=\"-1\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNGPz04dJAuX8PzfDu1KjpUtggD10w&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779404104922&amp;ei=KcC3WMjVL4qX3wGC-YfYAw&amp;url=https:\/\/www.equitiesfocus.com\/puma-biotechnology-inc-nysepbyi-registers-a-net-consolidated-eps-of-7-4483-4\/1241230\/\">Puma <b>Biotechnology<\/b> Inc (NYSE:PBYI) Registers a Net Consolidated EPS Of $-7.4483<\/a><font size=\"-1\" color=\"#6f6f6f\"><nobr>Equities Focus<\/nobr><\/font><\/font><br><font size=\"-1\" class=\"p\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNHf1CgQVj7v9XudRPOQXtOrv60hbQ&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779404104922&amp;ei=KcC3WMjVL4qX3wGC-YfYAw&amp;url=http:\/\/newsden.net\/analysts-price-targets\/puma-biotechnology-inc-nasdaqpbyi-analyst-coverage-3\/459494\"><nobr>NewsDen<\/nobr><\/a><\/font><br><font class=\"p\" size=\"-1\"><a class=\"p\" href=\"http:\/\/news.google.com\/news\/more?ncl=dCXCD1c6O1ZuRMMPnltZjH6boIM5M&amp;authuser=0&amp;ned=us\"><nobr><b>all 6 news articles&nbsp;&raquo;<\/b><\/nobr><\/a><\/font><\/div><p><\/p><\/font><\/td><\/tr><\/table><p><!-- Auto Generated --><\/p><p>See the original post here:<br><a target=\"_blank\" href=\"https:\/\/marketexclusive.com\/puma-biotechnology-inc-nasdaqpbyi-files-an-8-k-other-events-2\/77816\/\" title=\"PUMA BIOTECHNOLOGY, INC. (NASDAQ:PBYI) Files An 8-K Other Events - Market Exclusive\" rel=\"noopener\">PUMA BIOTECHNOLOGY, INC. (NASDAQ:PBYI) Files An 8-K Other Events - Market Exclusive<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p> PUMA BIOTECHNOLOGY , INC. (NASDAQ:PBYI) Files An 8-K Other Events Market Exclusive Puma Biotechnology , Inc. is a biopharmaceutical company that focuses on the development and commercialization of products for the treatment of cancer <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/puma-biotechnology-inc-nasdaqpbyi-files-an-8-k-other-events-market-exclusive.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246860],"tags":[],"class_list":["post-130686","post","type-post","status-publish","format-standard","hentry","category-biotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/130686"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=130686"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/130686\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=130686"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=130686"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=130686"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}